References

Borderline personality disorder

2022 · External reference

Borderline personality disorder

10.1016/s0140-6736(21)00476-1 · 2021 · External reference

Pro re nata (as needed) psychotropic medication use in patients with borderline personality disorder and subjects with other personality disorders over 14 years of prospective follow-up

10.1097/jcp.0000000000000132 · 2014 · External reference

Psychopharmacological treatment of 2195 in-patients with borderline personality disorder: a comparison with other psychiatric disorders

10.1016/j.euroneuro.2015.03.017 · 2015 · External reference

Rates of psychotropic medication use reported by borderline patients and axis II comparison subjects over 16 years of prospective follow-up

10.1097/jcp.0000000000000232 · 2015 · External reference

Psychopharmacological treatment in borderline personality disorder: a pilot observational study in a real-world setting

10.1016/j.psychres.2020.113556 · 2021 · External reference

Pharmacological treatments for borderline personality disorder: a systematic review and meta-analysis

10.1007/s40263-021-00855-4 · 2021 · External reference

Antipsychotics, antidepressants, anticonvulsants, and placebo on the symptom dimensions of borderline personality disorder: a meta-analysis of randomized controlled and open-label trials

10.1097/jcp.0b013e31822c1636 · 2011 · External reference

Pharmacological management of borderline personality disorder and common comorbidities

10.1007/s40263-023-01015-6 · 2023 · External reference

Differential effectiveness of antipsychotics in borderline personality disorder: meta-analyses of placebo-controlled, randomized clinical trials on symptomatic outcome domains

10.1097/jcp.0b013e3182217a69 · 2011 · External reference

Current clinical psychopharmacology in borderline personality disorder

10.2174/1570159x19666210610092958 · 2021 · External reference

Efficacy and safety of aripiprazole in borderline personality disorder: a systematic review

10.1007/s11126-023-10045-8 · 2023 · External reference

Prescribing of antipsychotics among people with recorded personality disorder in primary care: a retrospective nationwide cohort study using The Health Improvement Network primary care database

10.1136/bmjopen-2021-053943 · 2022 · External reference

Absolute neutrophil count and adverse drug reaction monitoring during clozapine treatment: consensus guidelines from a global Delphi panel

10.1016/s2215-0366(25)00098-7 · 2026 · External reference

Low-dose clozapine in acute and continuation treatment of severe borderline personality disorder

10.4088/jcp.v59n0302 · 1998 · External reference

Clozapine in severe borderline personality disorder

10.1080/09585180110091994 · 2001 · External reference

Medication for borderline personality disorder: a survey at a secure hospital

10.3109/13651501.2011.590211 · 2011 · External reference

A case series of clozapine for borderline personality disorder

10.1177/104012371302500207 · 2013 · External reference

Experiences of women in secure care who have been prescribed clozapine for borderline personality disorder

10.1186/s40479-016-0049-x · 2016 · External reference

Real-world effectiveness of clozapine for borderline personality disorder: results from a 2-year mirror-image study

10.1521/pedi_2017_31_328 · 2018 · External reference

A systematic review of the role of clozapine for severe borderline personality disorder

10.1007/s00213-023-06431-6 · 2023 · External reference

Off-label use of second-generation antipsychotics in borderline personality disorder: a survey of Italian psychiatrists

10.1521/pedi_2019_33_445 · 2021 · External reference

Cultural adaptation of the difficulties in emotion regulation scale: reliability and validity of an Italian version

10.1002/jclp.21876 · 2012 · External reference

The Dissociative Experiences Scale: the dissociative experience of a sample of Italian students

2001 · External reference

Presentation of the Beck Depression Inventory-Second edition (BDI-II): confirmation of the bifactorial structure in a champion of the Italian population

2006 · External reference

Psychometric properties of an Italian version of the Barratt Impulsiveness Scale-11 (BIS-11) in nonclinical subjects

10.1002/jclp.1051 · 2001 · External reference

Quality of life assessment: validation of the Italian version of the WHOQOL-Brief

10.1017/s1121189x00007740 · 2000 · External reference

Glasgow antipsychotic side-effects scale for clozapine — development and validation of a clozapine-specific side-effects scale

10.1016/j.schres.2015.07.052 · 2015 · External reference

Pathological dissociation and neuropsychological functioning in borderline personality disorder

10.1111/j.1600-0447.2008.01323.x · 2009 · External reference

Dissociation in psychiatric disorders: a meta-analysis of studies using the dissociative experiences scale

10.1176/appi.ajp.2017.17010025 · 2018 · External reference

Adolescent suicide risk and experiences of dissociation in daily life

10.1016/j.psychres.2020.112870 · 2020 · External reference

Treatment of severe borderline personality disorder with clozapine

10.4103/0019-5545.70989 · 2010 · External reference

Clozapine for self-injurious behavior in individuals with borderline personality disorder

10.1177/2045125313484323 · 2013 · External reference

Use of clozapine for borderline personality disorder: a case report

10.9758/cpn.2016.14.2.226 · 2016 · External reference

Clozapine for the management of suicidal behavior in borderline personality disorder complicated by a cancer diagnosis: a case report and review of the literature

10.1097/jcp.0000000000000970 · 2018 · External reference

The protective effect of clozapine on suicide

10.4088/jcp.22m14587 · 2023 · External reference

Factors associated with pharmacological and psychotherapy treatments adherence in patients with borderline personality disorder

10.3389/fpsyt.2022.1056050 · 2022 · External reference